Release Details

Live Audio Webcast Thursday, September 8, 2005

SAN DIEGO, Sept. 6 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at the Thomas Weisel Partners Healthcare Tailwinds Conference Thursday, September 8, 2005 at 10:20AM Eastern Time (ET) / 7:20AM Pacific Time (PT) at the Four Seasons Hotel in Boston. The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com

Gary Lyons, President and Chief Executive Officer of Neurocrine will present a Company overview that will include marketing highlights for indiplon and provide an update on Neurocrine's broad development pipeline and research programs.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster. A replay will become available approximately three hours after the live event concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Thursday, September 22, 2005.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com

SOURCE Neurocrine Biosciences, Inc.
09/06/2005
CONTACT: Claudia Woodworth, or Elizabeth Foster, both of Neurocrine Biosciences, Inc., +1-858-617-7600
Web site: http://www.neurocrine.com
(NBIX)